Literature DB >> 22595268

Immigrant screening for TB: a missed opportunity to improve TB control in the United Kingdom.

Ajit Lalvani1, Manish Pareek.   

Abstract

Tuberculosis in the United Kingdom and other high-income countries is primarily a disease of the foreign-born arising from the synergy of migration from high TB burden regions and the reactivation of remotely acquired latent TB infection. UK immigrant screening policy primarily aims to identify active, rather than latent, TB although mounting evidence indicates that implementing latent TB screening for new entrants from intermediate and high incidence countries could cost-effectively reduce TB incidence in the UK.

Entities:  

Mesh:

Year:  2012        PMID: 22595268      PMCID: PMC4001505          DOI: 10.1179/204777312X13305103762501

Source DB:  PubMed          Journal:  Pathog Glob Health        ISSN: 2047-7724            Impact factor:   2.894


  2 in total

1.  Tuberculosis screening of migrants to low-burden nations: insights from evaluation of UK practice.

Authors:  M Pareek; I Abubakar; P J White; G P Garnett; A Lalvani
Journal:  Eur Respir J       Date:  2010-11-11       Impact factor: 16.671

2.  Screening of immigrants in the UK for imported latent tuberculosis: a multicentre cohort study and cost-effectiveness analysis.

Authors:  Manish Pareek; John P Watson; L Peter Ormerod; Onn Min Kon; Gerrit Woltmann; Peter J White; Ibrahim Abubakar; Ajit Lalvani
Journal:  Lancet Infect Dis       Date:  2011-04-20       Impact factor: 25.071

  2 in total
  6 in total

1.  Pre-entry screening for tuberculosis: the need for better evidence.

Authors:  Ajit Lalvani; Manish Pareek; Luis C Berrocal Almanza
Journal:  Pathog Glob Health       Date:  2015-03       Impact factor: 2.894

2.  Community-based testing of migrants for infectious diseases (COMBAT-ID): impact, acceptability and cost-effectiveness of identifying infectious diseases among migrants in primary care: protocol for an interrupted time-series, qualitative and health economic analysis.

Authors:  Manish Pareek; Helen C Eborall; Fatimah Wobi; Kate S Ellis; Evangelos Kontopantelis; Fang Zhang; Rebecca Baggaley; T Deirdre Hollingsworth; Darrin Baines; Hemu Patel; Pranabashis Haldar; Mayur Patel; Iain Stephenson; Ivan Browne; Paramjit Gill; Rajesh Kapur; Azhar Farooqi; Ibrahim Abubakar; Chris Griffiths
Journal:  BMJ Open       Date:  2019-03-07       Impact factor: 2.692

3.  Targeting screening and treatment for latent tuberculosis infection towards asylum seekers from high-incidence countries - a model-based cost-effectiveness analysis.

Authors:  Florian M Marx; Barbara Hauer; Nicolas A Menzies; Walter Haas; Nita Perumal
Journal:  BMC Public Health       Date:  2021-11-26       Impact factor: 4.135

4.  Mind the gap: TB trends in the USA and the UK, 2000-2011.

Authors:  Chimeremma D Nnadi; Laura F Anderson; Lori R Armstrong; Helen R Stagg; Debora Pedrazzoli; Robert Pratt; Charles M Heilig; Ibrahim Abubakar; Patrick K Moonan
Journal:  Thorax       Date:  2016-02-23       Impact factor: 9.139

5.  How should I interpret an interferon gamma release assay result for tuberculosis infection?

Authors:  Ibrahim Abubakar; Helen Ruth Stagg; Hilary Whitworth; Ajit Lalvani
Journal:  Thorax       Date:  2013-03       Impact factor: 9.139

6.  Effectiveness of nationwide programmatic testing and treatment for latent tuberculosis infection in migrants in England: a retrospective, population-based cohort study.

Authors:  Luis C Berrocal-Almanza; Ross J Harris; Simon M Collin; Morris C Muzyamba; Olivia D Conroy; Adil Mirza; Anne-Marie O'Connell; Lynn Altass; Sarah R Anderson; H Lucy Thomas; Colin Campbell; Dominik Zenner; Nick Phin; Onn Min Kon; E Grace Smith; Ajit Lalvani
Journal:  Lancet Public Health       Date:  2022-03-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.